MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Tanaffos · 2025

Iron Supplementation in Anemic Patients with Cystic Fibrosis: Effects on Hematologic, Clinical, and Pulmonary Outcomes.

Hokmabadi Soheila, Hassanzad Maryam, Ghaffaripour Hosseinali, Malek Fatemeh, Pourabdollah Mihan, Farnia Poopak, Mohammadpour-Belvirdy Leila, Velayati Ali Akbar

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Cystic fibrosis (CF) is an autosomal recessive multisystem disorder frequently complicated by anemia. This study aimed to evaluate the clinical, laboratory, radiological, and functional outcomes of oral iron therapy in anemic patients with CF.

MATERIALS AND

METHODS

In this interventional before-after study, 340 patients with confirmed CF were screened for anemia. Twenty-two patients met the diagnostic criteria for anemia, and 15 completed the study and were included in the final analysis. Participants received oral ferrous sulfate at a dose of 4-6 mg/kg/day (maximum 150 mg/day) for 6-8 weeks. Demographic characteristics, CBC, iron profile, inflammatory markers, pulmonary function tests, sputum culture, high-resolution computed tomography (HRCT) findings, and Shwachman-Kulczycki scores were evaluated before and after treatment.

RESULTS

The prevalence of anemia among patients with CF was 6.47% (22/340). The mean age of participants was 18.8±1.24 years, and 53.3% were male. Hemoglobin and hematocrit levels increased significantly following treatment, with the greatest improvement observed among patients with combined iron deficiency anemia (IDA) and anemia of chronic inflammation (ACI) (p=0.007 and p=0.014, respectively). Serum iron levels also increased significantly after treatment (p=0.040). No significant changes were observed in pulmonary function indices, sputum culture results, or HRCT findings. Physical examination scores within the Shwachman-Kulczycki assessment improved significantly in the IDA+ACI group (p=0.039). Hemoglobin and ferritin levels showed significant direct and inverse correlations with the total Shwachman-Kulczycki score, respectively (p=0.003 and p=0.015).

CONCLUSION

Short-term oral ferrous sulfate therapy improved hematologic and selected clinical outcomes in anemic CF patients without evidence of worsening pulmonary infection or respiratory status. Accurate identification of anemia etiology and appropriate management may improve patient outcomes, although longer-term follow-up studies are warranted.

Для цитирования: Hokmabadi Soheila, Hassanzad Maryam, Ghaffaripour Hosseinali, Malek Fatemeh, Pourabdollah Mihan, Farnia Poopak, Mohammadpour-Belvirdy Leila, Velayati Ali Akbar. Iron Supplementation in Anemic Patients with Cystic Fibrosis: Effects on Hematologic, Clinical, and Pulmonary Outcomes.. Tanaffos. 2025.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.